#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Uterine leiomyosarcoma Osteomyelitis Breast cancer Hereditary spastic paraplegia Stress cardiomyopathy Antiphospholipid syndrome Anti-neutrophil cytoplasmic antibody positive vasculitis Mitochondrial DNA depletion Neuromyelitis optica spectrum disorder Phaeochromocytoma Rett syndrome Cutaneous T-cell lymphoma stage II Soft tissue necrosis Liposarcoma metastatic PIK3CA-activated mutation More trials…

    Learn about Rare Diseases

    Mastocytosis Wiskott-Aldrich syndrome – Trials in Disease Mucopolysaccharidosis III – Treatment Primary mediastinal large B-cell lymphoma – Treatment Primary hyperoxaluria Piriformis syndrome – Treatment Noonan syndrome Immunodeficiency congenital – Diagnostics Niemann-Pick disease – Treatment Leukoencephalopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZIMISLECEL INDAPAMIDE HEMIHYDRATE Eletriptan Tetrahydrouridine Purified Egg Phospholipids Ivonescimab [14C]ZIPALERTINIB Tinlarebant Almagate Nafarelin PHENTOLAMINE MESILATE Oseltamivir Emavusertib Siplizumab Nitric Oxide IDROXIOLEIC ACID ARFOLITIXORIN Olanzapine Dorocubicel Nadroparin Calcium More therapies…

    Learn about Your Condition

    Paraganglion neoplasm Mast cell activation syndrome Hypotension Chronic hepatitis B Oral neoplasm Tumour thrombosis Fibrosarcoma Aphthous ulcer Noonan syndrome Binge eating Underweight Oesophageal achalasia Affective disorder Gastric cancer recurrent Skin candida More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Schizophrenia

  • Study on Improving Social Skills in Schizophrenia Using Oxytocin or Placebo as an Add-On Treatment for Patients with Schizophrenia Spectrum Disorders

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Psychotic disorder
    • Schizophrenia
    Investigated Drugs:
    • Oxytocin
    Germany

  • Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    • Schizophrenia
    • Bipolar disorder
    Investigated Drugs:
    • Lithium
    • Clozapine
    • Esketamine
    Austria Germany Italy Spain

  • Study on the Effectiveness and Safety of Cariprazine for Adolescents (13-17 years) with Schizophrenia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Cariprazine Hydrochloride
    • Cariprazine
    Bulgaria Romania

  • Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria

  • Study on Rituximab for Adults with Schizophrenia Spectrum Disorder

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Rituximab
    Sweden

  • Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Valbenazine Ditosylate
    Bulgaria Croatia Czechia Romania Slovakia Spain
Previous Page
1 … 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!